Infectious diseases (London, England) (Infect Dis (Lond))

Journal PubWeight™ 111.50‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Risk factors for disease progression in hospitalized patients with COVID-19: a retrospective cohort study. 2020 5.86
2 A case of imported COVID-19 diagnosed by PCR-positive lower respiratory specimen but with PCR-negative throat swabs. 2020 4.20
3 Positive RT-PCR test results after consecutively negative results in patients with COVID-19. 2020 3.30
4 Antiretroviral treatment for HIV infection: Swedish recommendations 2016. 2016 1.44
5 Complications following intravesical bacillus Calmette-Guerin treatment for bladder cancer: a case series of 22 patients. 2015 1.42
6 Diagnostic utility of biomarkers for neonatal sepsis--a systematic review. 2014 1.42
7 Review of the pharmacokinetics of dalbavancin, a recently approved lipoglycopeptide antibiotic. 2017 1.42
8 Incidence and mortality of sepsis, severe sepsis, and septic shock in intensive care unit patients with candidemia. 2015 1.39
9 Validate or falsify: Lessons learned from a microscopy method claimed to be useful for detecting Borrelia and Babesia organisms in human blood. 2016 1.39
10 Human infection with a highly pathogenic avian influenza A (H5N6) virus in Yunnan province, China. 2016 1.39
11 Chlamydia trachomatis infection in young adults - association with concurrent partnerships and short gap length between partners. 2015 1.38
12 Acute fulminant vs. acute-on-chronic liver failure in hepatitis E: diagnostic implications. 2014 1.06
13 Post liposuction infections by rapidly growing mycobacteria. 2014 1.03
14 Fecal microbiota transplantation for the intestinal decolonization of extensively antimicrobial-resistant opportunistic pathogens: a review. 2016 0.95
15 Epidemiological factors associated with ESBL- and non ESBL-producing E. coli causing urinary tract infection in general practice. 2015 0.95
16 The changing epidemiology of group B streptococcus bloodstream infection: a multi-national population-based assessment. 2016 0.93
17 Coexistence of two clades of enterovirus D68 in pediatric Swedish patients in the summer and fall of 2014. 2015 0.92
18 Drug susceptibility and molecular epidemiology of Escherichia coli in bloodstream infections in Shanghai, China, 2011-2013. 2015 0.92
19 Dramatic increase in laboratory-diagnosed human cutaneous leishmaniasis cases in southern Israel, 2007-2013. 2015 0.91
20 Infections on the rise: Raoultella spp., clinical and microbiological findings from a retrospective study, 2010-2014. 2015 0.90
21 Epidemiology of pneumococcal carriage in children under five years of age in Accra, Ghana. 2015 0.88
22 Risk factors of severe hand, foot and mouth disease complicated with cardiopulmonary collapse. 2015 0.87
23 Prevalence of polymorphisms with significant resistance to NS5A inhibitors in treatment-naive patients with hepatitis C virus genotypes 1a and 3a in Sweden. 2015 0.86
24 Characterization of ESBL disseminating plasmids. 2015 0.86
25 Oral human papillomavirus (HPV) prevalence in youth and cervical HPV prevalence in women attending a youth clinic in Sweden, a follow up-study 2013-2014 after gradual introduction of public HPV vaccination. 2014 0.85
26 Fatal pneumonia cases caused by human adenovirus 55 in immunocompetent adults. 2015 0.85
27 Pseudomonas oryzihabitans: an unusual cause of skin and soft tissue infection. 2015 0.84
28 Elevated fecal calprotectin associates with adverse outcomes from Clostridium difficile infection in older adults. 2016 0.84
29 The financial crisis and the expected effects on vaccinations in Europe: a literature review. 2015 0.84
30 Rothia mucilaginosa pneumonia: a literature review. 2015 0.84
31 Vasculitis and stroke due to Lyme neuroborreliosis - a review. 2014 0.83
32 PCR for enteric pathogens in high-prevalence settings. What does a positive signal tell us? 2015 0.83
33 Key demographic characteristics of patients with bacteriuria due to extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in a multiethnic community, in North West London. 2015 0.82
34 Antibiotic prescribing in medical intensive care units--a comparison between two private sector hospitals in Central India. 2015 0.82
35 Evaluation of the Cobas TaqMan MTB test for detection of Mycobacterium tuberculosis complex. 2015 0.82
36 Use of sofosbuvir-based direct-acting antiviral therapy for hepatitis C viral infection in patients with severe renal insufficiency. 2015 0.82
37 Design and structure of the Estonian HIV Cohort Study (E-HIV). 2015 0.81
38 Functional polymorphisms in the gene encoding macrophage migration inhibitory factor (MIF) are associated with active pulmonary tuberculosis. 2015 0.81
39 Infection with Babesia microti in humans with non-specific symptoms in North East Poland. 2016 0.81
40 Seroprevalence of antibodies to tick-borne encephalitis virus and Anaplasma phagocytophilum in healthy adults from western Norway. 2014 0.81
41 Six-week follow-up after HIV-1 exposure: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy. 2015 0.81
42 A Monte Carlo pharmacokinetic/pharmacodynamic simulation to evaluate the efficacy of minocycline, tigecycline, moxifloxacin, and levofloxacin in the treatment of hospital-acquired pneumonia caused by Stenotrophomonas maltophilia. 2015 0.81
43 Characteristics and outcomes of Klebsiella pneumoniae bacteraemia in Hong Kong. 2015 0.81
44 Ventilator-associated pneumonia rates after introducing selective digestive tract decontamination. 2015 0.80
45 Fighting an old disease with modern tools: characteristics and molecular detection methods of drug-resistant Mycobacterium tuberculosis. 2015 0.80
46 Interleukin-27 improves the ability of adenosine deaminase to rule out tuberculous pleural effusion regardless of pleural tuberculosis prevalence. 2015 0.80
47 Sulbactam treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex. 2015 0.80
48 Changes in pneumococcal nasopharyngeal colonization among children with respiratory tract infections before and after use of the two new extended-valency pneumococcal conjugated vaccines. 2015 0.80
49 From Pakistan a line of hope for 'The Polio Eradication and Endgame Strategic Plan 2013-2018'. 2015 0.80
50 Decrease in seroprevalence for herpesviruses among pregnant women in Finland: cross-sectional study of three time points 1992, 2002 and 2012. 2015 0.80
Next 50